Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

Overall Survival with Osimertinib in Untreated, <i>EGFR</i> -Mutated Advanced NSCLC

PaperCitations, authors & open-access status

Overall Survival with Osimertinib in Untreated, <i>EGFR</i> -Mutated Advanced NSCLC is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 2,875 citations, 2019 year and bronze oa status.

2,875
Citations
2019
Year
bronze
OA Status

Related on ScholarIQ

Jhanelle E. Gray
Author
David Planchard
Author
Ying Cheng
Author
New England Journal of Medicine
Journal
Lung Cancer Treatments and Mutations
Topic
Lung Cancer Treatments and Mutations
Topic
470M+ articles · free account